Clinical Trials List
2023-04-01 - 2032-12-31
Phase III
Recruiting9
ICD-10I70.0
Atherosclerosis of aorta
ICD-9440.0
Atherosclerosis of aorta
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- 李慶威 Division of Cardiovascular Diseases
- 黃偉銘 無
- Hao-min Cheng Division of Cardiovascular Diseases
- 吳承學 無
- 郭泠 無
- Tze-Fan Chao 無
- Chern-En Chiang Division of Cardiovascular Diseases
- Shih-Hsien Sung Division of Cardiovascular Diseases
- 黃少嵩 無
- 蔡依霖 無
- Wen-Chung Yu Division of Cardiovascular Diseases
- 張俊欽 無
- 廖若男 無
- Tse-Min Lu Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 葉美成 Division of Cardiovascular Diseases
- 洪俊聲 Division of Cardiovascular Diseases
- 黃聖中 Division of Cardiovascular Diseases
- 曾冠叡 Division of Cardiovascular Diseases
- 周銘霆 Division of Cardiovascular Diseases
- 蔣俊彥 Division of Cardiovascular Diseases
- Hao-Chang Hung Division of Cardiovascular Diseases
- 施志遠 Division of Cardiovascular Diseases
- 黃偉輔 Division of Cardiovascular Diseases
- 林志憲 Division of Cardiovascular Diseases
- 李威杰 Division of Cardiovascular Diseases
- 張瑋婷 Division of Cardiovascular Diseases
- Chia-Te Liao Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 吳韋璁 Division of Cardiovascular Diseases
- 黃天祈 Division of Cardiovascular Diseases
- Cheng-An Chiu Division of Cardiovascular Diseases
- Chun-Yuan Chu Division of Cardiovascular Diseases
- Po-Chao Hsu Division of Cardiovascular Diseases
- Ye-Hsu Lu Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yung-Ta Kao Division of Cardiovascular Diseases
- Tsung-Lin Yang Division of Cardiovascular Diseases
- 陳彥舟 Division of Cardiovascular Diseases
- 蕭卜源 Division of Cardiovascular Diseases
- Chien-Yi Hsu Division of Cardiovascular Diseases
- 陳志維 Division of Cardiovascular Diseases
- 鄭宇倫 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 陳東藝 Division of Cardiovascular Diseases
- 林怡瑄 Division of Cardiovascular Diseases
- 葉日凱 Division of Cardiovascular Diseases
- 陳怡文 Division of Cardiovascular Diseases
- 劉鳳炫 Division of Cardiovascular Diseases
- 何明昀 Division of Cardiovascular Diseases
- 陳俊吉 Division of Cardiovascular Diseases
- 謝明哲 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 林晏年 Division of Cardiovascular Diseases
- 王宇澄 Division of Cardiovascular Diseases
- 陳恬恩 Division of Cardiovascular Diseases
- 吳宏彬 Division of Cardiovascular Diseases
- Lien-Cheng Hsiao Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
200-400 participants
-
Global
14000 participants
